[
  {
    "ts": "2025-12-03T16:30:04+00:00",
    "headline": "Axsome (AXSM) Up 5.3% Since Last Earnings Report: Can It Continue?",
    "summary": "Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finance.yahoo.com/news/axsome-axsm-5-3-since-163004550.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "2fcc6617-e776-31da-b6ba-0efe66e72d2e",
      "content": {
        "id": "2fcc6617-e776-31da-b6ba-0efe66e72d2e",
        "contentType": "STORY",
        "title": "Axsome (AXSM) Up 5.3% Since Last Earnings Report: Can It Continue?",
        "description": "",
        "summary": "Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
        "pubDate": "2025-12-03T16:30:04Z",
        "displayTime": "2025-12-03T16:30:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/62d8c8e05376a18ba1420a1733ffdda4",
          "originalWidth": 900,
          "originalHeight": 601,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PIdvgNQlfpuBODSIZCqYyg--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/62d8c8e05376a18ba1420a1733ffdda4.cf.webp",
              "width": 900,
              "height": 601,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sAMTWSt0tSP35kyVmwadNw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/62d8c8e05376a18ba1420a1733ffdda4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/axsome-axsm-5-3-since-163004550.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/axsome-axsm-5-3-since-163004550.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AXSM"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-03T22:13:53+00:00",
    "headline": "Is Vera Therapeutics (VERA) Quietly Recasting Its Commercial Strategy With the Meyers Board Appointment?",
    "summary": "Vera Therapeutics recently appointed James R. Meyers, a biopharmaceutical executive with more than three decades of commercial leadership at companies including Gilead and AstraZeneca, to its Board of Directors. Meyers’ track record in leading global launches in HIV and HCV and guiding Gilead’s evolution into a large, profitable biopharma adds weight to Vera’s commercial ambitions as it advances its pipeline. We’ll now examine how adding Meyers’ extensive commercial expertise to the board...",
    "url": "https://finance.yahoo.com/news/vera-therapeutics-vera-quietly-recasting-221353781.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "0a27b132-0cfc-37a3-a0ad-35f48143b0a4",
      "content": {
        "id": "0a27b132-0cfc-37a3-a0ad-35f48143b0a4",
        "contentType": "STORY",
        "title": "Is Vera Therapeutics (VERA) Quietly Recasting Its Commercial Strategy With the Meyers Board Appointment?",
        "description": "",
        "summary": "Vera Therapeutics recently appointed James R. Meyers, a biopharmaceutical executive with more than three decades of commercial leadership at companies including Gilead and AstraZeneca, to its Board of Directors. Meyers’ track record in leading global launches in HIV and HCV and guiding Gilead’s evolution into a large, profitable biopharma adds weight to Vera’s commercial ambitions as it advances its pipeline. We’ll now examine how adding Meyers’ extensive commercial expertise to the board...",
        "pubDate": "2025-12-03T22:13:53Z",
        "displayTime": "2025-12-03T22:13:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FqD7IP1YjoMtOLiC1foWBQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DnvRJ7zmyZqa8oFdfcLgCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vera-therapeutics-vera-quietly-recasting-221353781.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vera-therapeutics-vera-quietly-recasting-221353781.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VERA"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "AZN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]